Science
Mechanism of Action
PCTFE functions primarily as an inert barrier and film-forming agent on the skin's surface. Its molecular structure prevents active biological interaction, instead focusing on creating a stable, chemically resistant film that significantly reduces moisture absorption.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
PCTFE exhibits remarkable stability, maintaining its properties across an exceptionally broad temperature range, from approximately -230°C to 201°C, and demonstrating excellent resistance to acids, bases, and oxidizing agents. Its near-zero moisture absorption further contributes to its robust stability profile.
Conflicts
- Practical processing is challenged by its solubility, which is limited to a few highly toxic organic solvents at elevated temperatures exceeding 100°C.
- Melt processing is difficult due to a high melting temperature and viscosity, with decomposition occurring close to its melting point.
- Degradation during processing can release corrosive byproducts, such as hydrogen fluoride (HF), necessitating specialized corrosion-resistant equipment.
- Slight swelling may occur in contact with halocarbon compounds, ethers, esters, and aromatic substances.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not specifically evaluated PCTFE, and data for fluorinated polymers are often insufficient, though PTFE has been deemed safe. PCTFE is physiologically inert and generally exhibits low toxicity, with FDA-compliant grades used in food contact, medical devices, and packaging. However, the FDA notes that further research is required to fully assess the safety of certain per- and polyfluoroalkyl substances (PFAS), including PCTFE, in cosmetic applications due to incomplete toxicological data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Polychlorotrifluoroethylene is an inert, highly stable polymer with potential as a barrier or film-forming agent; however, comprehensive cosmetic-specific clinical efficacy and safety data are currently insufficient, and its classification as a PFAS warrants further toxicological investigation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources